Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -131,445 | -109,010 | -72,995 | -34,883 | -4,682 |
| Depreciation Amortization | 2,583 | 1,937 | 1,287 | 646 | 1,247 |
| Accounts receivable | -4,080 | 173 | -107 | 170 | 124 |
| Accounts payable and accrued liabilities | 13,584 | 18,705 | 5,818 | 3,836 | 6,203 |
| Other Working Capital | -53,531 | -24,795 | -25,157 | -12,315 | 171,891 |
| Other Operating Activity | -2,739 | -13,847 | -464 | -1,194 | 9,993 |
| Operating Cash Flow | $-175,628 | $-126,837 | $-91,618 | $-43,740 | $184,776 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 18,483 | -38,124 | -72,037 | -133,586 | -116,446 |
| PPE Investments | -231 | -83 | -67 | -54 | -575 |
| Investing Cash Flow | $18,252 | $-38,207 | $-72,104 | $-133,640 | $-117,021 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2,016 | -1,495 | -988 | -491 | -1,859 |
| Common Stock Issued | 3,624 | 2,943 | 752 | 184 | 114 |
| Common Stock Repurchased | -621 | -621 | -621 | -621 | -357 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 70 |
| Financing Cash Flow | $987 | $827 | $-857 | $-928 | $-2,032 |
| Beginning Cash Position | 202,989 | 202,989 | 202,989 | 202,989 | 137,266 |
| End Cash Position | 46,600 | 38,772 | 38,410 | 24,681 | 202,989 |
| Net Cash Flow | $-156,389 | $-164,217 | $-164,579 | $-178,308 | $65,723 |
| Free Cash Flow | |||||
| Operating Cash Flow | -175,628 | -126,837 | -91,618 | -43,740 | 184,776 |
| Capital Expenditure | -231 | -83 | -67 | -54 | -910 |
| Free Cash Flow | -175,859 | -126,920 | -91,685 | -43,794 | 183,866 |